Sandoz Says Antitrust Row Can't Hinge On Drug Patent Case
Amphastar Pharmaceuticals Inc. can't claim that a victory in an unresolved patent dispute should allow it to score a partial win on key claims of a separate antitrust suit accusing two...To view the full article, register now.
Already a subscriber? Click here to view full article